Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
follitropin beta
- Development stage
- Approved
- Lead developer
- Merck
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intramuscular
01
Overview
Follitropin beta is a recombinant form of human follicle-stimulating hormone (FSH), produced using genetically engineered Chinese hamster ovary (CHO) cells. It consists of two non-covalently linked glycoprotein subunits (alpha and beta). As a gonadotropin, it stimulates ovarian follicular growth in women with ovulatory dysfunction and promotes spermatogenesis in men with hypogonadotropic hypogonadism. In women, it is used to induce ovulation and as part of assisted reproductive technology procedures such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), often in combination with human chorionic gonadotropin (hCG). In men, it is used after hCG pretreatment to increase sperm production. The drug replaces natural FSH when endogenous levels are insufficient for normal reproductive function[1][2][5][8].
- Brand names
- FollistimFollistim AQGonal-f RFF
- Other names
- follicle-stimulating hormone recombinantrecombinant human follicle-stimulating hormone
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on follitropin beta.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on follitropin beta.